Upgrading the HIV vaccine paradigm: accounting for host-pathogen diversity through geotargeting-based vaccine design
5 affiliations
- 1Grupo Hospitalar Conceicao , ,
- 2Universidade Federal do Rio Grande do Sul , ,
- 3PPG Biosaúde Ulbra, Universidade Luterana do Brasil , ,
- 4Responsabilidade Social, Hospital Moinhos de Vento , ,
- 5Department of Biology and Biochemistry, University of Houston , , ,
Abstract
Introduction: Effective HIV vaccine development, with satisfactory levels of response and coverage, remains an elusive goal in immunology. In this context, considerations of host-pathogen interactions from a geotargeting perspective could enhance disease control efforts. Current HIV vaccine strategies increasingly seek to address viral diversity, but the combined effects of regional viral variation and host HLA diversity on antigen processing and presentation remain insufficiently considered. Here, we evaluated whether integrating these host–pathogen variables could support geographically informed prioritization of HIV vaccine targets.
Methods: Using NetMHCpan 4.1, NetChop 3.1, and the IEDB antigen-processing prediction tool, we evaluated antigen-processing and presentation steps for HIV epitopes associated with viral control. We recovered Human Leukocyte Antigen (HLA) alleles associated with HIV control and their frequencies, and the protein sequences for the most common HIV subtypes in different African countries. We created maps linking both sets of information for each specific region. We then predicted the impact of mutations associated with different HIV strain sequences on proteasome processing score, TAP transportation and HLA binding affinity for the alleles in each host population.
Results: The generated maps provide a landscape of the impact of genetic diversity on T cell responses for each examined epitope target. TW10 epitope variants in the main HIV subtypes showed consistent HLA binding, proteasome cleavage and processing rankings across the continent. Conversely, TI8 variants carrying I8T or I8R substitutions lost predicted HLA-B*51:01 binding and showed marked deterioration in the combined processing ranking, from 10th for the reference epitope to positions as low as 97th among the analyzed variants.
Discussion: The adoption of uniform immunotherapy strategies based solely on reference HIV epitopes may be an inefficient approach. Certain epitopes may be suitable vaccine targets for specific locations, when matching a prevalent HIV strain with a host population with high prevalence of HLA alleles that can effectively display the vaccine’s epitopes. However, HLA matching is not enough if the HIV strains in the region have upstream or downstream mutations that prevent the proper processing and presentation of the targeted viral epitope. Based on this complex host–pathogen interplay, we propose a geotargeting approach to vaccine design, considering customized targets for specific geographical locations and host populations. By incorporating regional viral and HLA diversity into target selection, this strategy may increase the likelihood of developing more effective HIV vaccines, although the resulting predictions will require experimental validation.
Related
- Cyanobacterial conversion of CO₂ to bio-based diols and downstream valorization: biological basis, upgrading strategies, and applications.
- Variable-resolution maps (VRMs) in CCTBX and Phenix : accounting for local resolution in cryoEM
- Target Discovery and Drug Intervention in Inflammatory Diseases： A Paradigm Shift from Mechanistic Dissection to Precision Therapy
- Poison exon splicing in the human brain provides a new paradigm for understanding and targeting neurological disorders
- Proximity labeling of the Listeria monocytogenes surface reveals pathogen control of a host deubiquitinase
BibTeX
@article{lunardi2026upgrading,
title = {{Upgrading the HIV vaccine paradigm: accounting for host-pathogen diversity through geotargeting-based vaccine design}},
author = {Luciano Lunardi and Alexandra de Azevedo Rocha and Ana Carolina Alves de Oliveira and Iuri Marques de Oliveira and Angelica Cerveira De Baumont and Dinler Amaral Antunes and Gustavo Fioravanti Vieira},
journal = {Frontiers in cellular and infection microbiology},
year = {2026},
month = oct,
doi = {10.3389/fcimb.2026.1927865},
url = {https://europepmc.org/article/PMC/PMC13719621},
note = {CC BY},
}
RIS
TY - JOUR
TI - Upgrading the HIV vaccine paradigm: accounting for host-pathogen diversity through geotargeting-based vaccine design
AU - Luciano Lunardi
AU - Alexandra de Azevedo Rocha
AU - Ana Carolina Alves de Oliveira
AU - Iuri Marques de Oliveira
AU - Angelica Cerveira De Baumont
AU - Dinler Amaral Antunes
AU - Gustavo Fioravanti Vieira
PY - 2026
DA - 2026/10/16
JO - Frontiers in cellular and infection microbiology
DO - 10.3389/fcimb.2026.1927865
UR - https://europepmc.org/article/PMC/PMC13719621
AB - Introduction: Effective HIV vaccine development, with satisfactory levels of response and coverage, remains an elusive goal in immunology. In this context, considerations of host-pathogen interactions from a geotargeting perspective could enhance disease control efforts. Current HIV vaccine strategies increasingly seek to address viral diversity, but the combined effects of regional viral variation and host HLA diversity on antigen processing and presentation remain insufficiently considered. Here, we evaluated whether integrating these host–pathogen variables could support geographically informed prioritization of HIV vaccine targets. Methods: Using NetMHCpan 4.1, NetChop 3.1, and the IEDB antigen-processing prediction tool, we evaluated antigen-processing and presentation steps for HIV epitopes associated with viral control. We recovered Human Leukocyte Antigen (HLA) alleles associated with HIV control and their frequencies, and the protein sequences for the most common HIV subtypes in different African countries. We created maps linking both sets of information for each specific region. We then predicted the impact of mutations associated with different HIV strain sequences on proteasome processing score, TAP transportation and HLA binding affinity for the alleles in each host population. Results: The generated maps provide a landscape of the impact of genetic diversity on T cell responses for each examined epitope target. TW10 epitope variants in the main HIV subtypes showed consistent HLA binding, proteasome cleavage and processing rankings across the continent. Conversely, TI8 variants carrying I8T or I8R substitutions lost predicted HLA-B*51:01 binding and showed marked deterioration in the combined processing ranking, from 10th for the reference epitope to positions as low as 97th among the analyzed variants. Discussion: The adoption of uniform immunotherapy strategies based solely on reference HIV epitopes may be an inefficient approach. Certain epitopes may be suitable vaccine targets for specific locations, when matching a prevalent HIV strain with a host population with high prevalence of HLA alleles that can effectively display the vaccine’s epitopes. However, HLA matching is not enough if the HIV strains in the region have upstream or downstream mutations that prevent the proper processing and presentation of the targeted viral epitope. Based on this complex host–pathogen interplay, we propose a geotargeting approach to vaccine design, considering customized targets for specific geographical locations and host populations. By incorporating regional viral and HLA diversity into target selection, this strategy may increase the likelihood of developing more effective HIV vaccines, although the resulting predictions will require experimental validation.
SN - 2235-2988
ER -